This workshop builds upon BLOODPAC’s pre-submission to the U.S. Food and Drug Administration (FDA), Increasing Patient Access and Standardizing Patient Blood Collection.

The goal of this workshop is to present BLOODPAC’s proposed pathways for liquid biopsy specimen collection and to gather stakeholder feedback. Insights and recommendations from these discussions will inform a forthcoming white paper intended to guide future efforts across the field. More details to come!